ArticleNeuroethics2017
Public Attitudes Towards Moral Enhancement. Evidence that Means Matter Morally.
Article in Neuroethics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Human Enhancement: A Conceptual Scoping Review.The Journal of medicine and philosophy · 2026Article
- Revolutionizing Brain Research Using Portable MRI in Field Settings: Public Perspectives on the Ethical and Legal Challenges.Neuroethics · 2025Article
- Evaluating Risk and Benefit Sensitivity for Cognitive Treatments.Journal of cognitive enhancement : towards the integration of theory and practice · 2025Article
- Neurointerventions for Criminal Offenders: Psychological Connectedness, Culpability and Justified Punishment.Ethical theory and moral practice : an international forum · 2025Article
- Right to mental integrity and neurotechnologies: implications of the extended mind thesis.Journal of medical ethics · 2024Article
- Public Views on Whether the Use of Pharmaceutical Neuroenhancements Should Be Allowed.Neurology · 2024Article
- A comparative review on neuroethical issues in neuroscientific and neuroethical journals.Frontiers in neuroscience · 2023Review
- On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective.Frontiers in psychology · 2023Review
- What drives public attitudes towards moral bioenhancement and why it matters: an exploratory study.BMC medical ethics · 2021Article
- Why a Virtual Assistant for Moral Enhancement When We Could have a Socrates?Science and engineering ethics · 2021Article
- Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.Science and engineering ethics · 2021Article
- Losing Meaning: Philosophical Reflections on Neural Interventions and their Influence on Narrative Identity.Neuroethics · 2021Article
- Evidence-Based Neuroethics, Deep Brain Stimulation and Personality - Deflating, but not Bursting, the Bubble.Neuroethics · 2021Article
- Can self-validating neuroenhancement be autonomous?Medicine, health care, and philosophy · 2020Article
- Hacking the Brain: Dimensions of Cognitive Enhancement.ACS chemical neuroscience · 2019Review
- Smarter Than Thou, Holier Than Thou: The Dynamic Interplay Between Cognitive and Moral Enhancement.Frontiers in pharmacology · 2018Article
- Bottom Up Ethics - Neuroenhancement in Education and Employment.Neuroethics · 2018Article
- Deep Brain Stimulation, Authenticity and Value.Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To gain insight into the reasons that the public may have for endorsing or eschewing pharmacological moral enhancement for themselves or for others, we used empirical tools to explore public attitudes towards these issues. Participants (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.